BioCentury
ARTICLE | Clinical News

Paracelsian regulatory update

April 1, 1996 8:00 AM UTC

Cornell Research Foundation Inc. received U.S. Patent No. 5,496,703 covering technology to detect dioxin-like compounds. PRLN is the exclusive licensee to the patent. The patent provides protection fo...